Cellebrite DI Ltd. shares dropped more than 30% after the company reported Q2 2026 annual recurring revenue (ARR) of approximately $507.8 million, missing both analyst expectations and its own guidance. The company also lowered its full-year 2026 ARR and revenue forecasts, reducing growth projections from 18%-19% to 14%-16%. This guidance cut triggered the selloff, and law firm Levi & Korsinsky has launched an investigation into potential securities law violations related to the company's statements and outlook. Investors who suffered losses may be eligible to seek recovery.
QUALCOMM is recommended as a Buy due to its strategic diversification and AI infrastructure projects expected to boost growth. The company aims to increase its non-handset revenue from 24% to over 60% by fiscal year 2027, offsetting declines related ...
American companies such as Nike, Starbucks, and General Motors are seeing their businesses shrink in China due to geopolitical tensions, rising domestic competition, and a disconnect with Chinese consumers. While some brands struggle, others like Lul...
SuperQ Quantum Computing Inc. conducted a live operational demonstration at Texas A&M University's Bush Combat Development Complex, showcasing its hybrid quantum-classical platform for real-time military decision support. The demo tested rapid re-tas...
NRED Intelligent Mining reported surface samples at its Wilmac Copper-Gold Project in British Columbia showing copper grades up to 1.67%, confirming high-grade mineralization. However, the strongest geophysical signals indicating potential larger sul...
The Amplify HACK Cybersecurity Covered Call ETF (HAKY) offers investors a 15% target yield by combining monthly income with exposure to the growing cybersecurity and tech sectors. Unlike traditional covered call ETFs, HAKY covers only about half its ...
